Airsculpt Technologies, Inc. (AIRS) Stock Price & Analysis
Airsculpt Technologies, Inc. (AIRS) fell 1.28% to USD 4.61 as of July 25, 2026 at 06:05 UTC, according to Nexqual real-time market data.
AIRS last closed at USD 4.67; the session ranged USD 4.55–4.75 on volume of 261,952 shares. Market capitalization is $325.22M, with a 52-week range of USD 1.51–12 (NGM). Source: Nexqual, July 25, 2026 at 06:05 UTC.
Key Statistics (as of July 25, 2026 at 06:05 UTC)
| Price | USD 4.61 |
|---|---|
| Change | ▼ 1.28% (down) |
| Previous Close | USD 4.67 |
| Open | USD 4.71 |
| Day Range | USD 4.55 – 4.75 |
| 52-Week Range | USD 1.51 – 12 |
| Volume | 261,952 shares |
| Market Cap | $325.22M |
| Exchange | NGM |
Technical Analysis (AIRS)
Nexqual's technical model rates AIRS "BUY" based on 4 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 06:05 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 49.41 (neutral) |
| vs SMA50 | Below (USD 4.82) |
| MACD | 0.01 (positive) |
Analyst Ratings (AIRS)
Wall Street analysts rate AIRS "Hold" based on 2 analysts, with a mean price target of USD 6.25 (range USD 4.5–8), per Nexqual as of July 25, 2026 at 06:05 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 6.25 |
| High Target | USD 8 |
| Low Target | USD 4.5 |
| Buy / Hold / Sell | 1 / 2 / 0 |
Earnings (AIRS)
| Next Earnings Date | 2026-08-07 |
|---|---|
| EPS Estimate | USD 0.02 |
| Revenue Estimate | $44.14M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -0.01 vs est -0.02 ▲ beat |
| 2025-12-31 | USD -0.02 vs est -0.02 ▲ beat |
| 2025-09-30 | USD -0.04 vs est -0.02 ▼ miss |
| 2025-06-30 | USD 0.02 vs est 0.02 ▲ beat |
Source: Nexqual, July 25, 2026 at 06:05 UTC.
Financials & Fundamentals (AIRS)
| Total Revenue | $151.84M |
|---|---|
| Revenue Growth (YoY) | +0.00% |
| Gross Margin | +66.06% |
| Operating Margin | -4.58% |
| Profit Margin | -7.39% |
| ROE | -12.63% |
| Debt / Equity | 70.83 |
| Current Ratio | 0.75 |
| Total Cash | $16.69M |
| Total Debt | $71.02M |
| Free Cash Flow | $13.02M |
Source: Nexqual, July 25, 2026 at 06:05 UTC.
Financial Health Score (AIRS)
Nexqual rates Airsculpt Technologies, Inc.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 06:05 UTC.
| Growth | Critical — Revenue -16% YoY (annual), sharp decline |
|---|---|
| Profitability | Solid — Gross margin 66%, operating -5% |
| Balance Sheet | Mixed — $17M cash vs $71M debt |
| Cash Flow | Solid — FCF $13M, 9% margin |
| Efficiency | Critical — ROE -13%, ROA -1.6% |
Ownership (AIRS)
| Insider Ownership | +43.06% |
|---|---|
| Institutional Ownership | +66.04% |
| Shares Outstanding | 70.55M |
| Float | 14.96M |
| Short % of Float | +7.82% |
Source: Nexqual, July 25, 2026 at 06:05 UTC.
Leadership (AIRS)
Airsculpt Technologies, Inc. is led by Yogesh Jashnani (age 43), CEO & Director, per Nexqual as of July 25, 2026 at 06:05 UTC.
| CEO & Director | Yogesh Jashnani (age 43) |
|---|---|
| Chief Financial Officer | Michael J. Arthur (age 37) |
| Chief Marketing Officer | Stephanie Evans Greene |
Major Backers & Investors (AIRS)
Notable institutional backers of Airsculpt Technologies, Inc. include Vesey Street Capital Partners, LLC, Balyasny Asset Management LP, FourWorld Capital Management, LLC, according to Nexqual as of July 25, 2026 at 06:05 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Vesey Street Capital Partners, LLC | 42.99% |
| Balyasny Asset Management LP | 3.3% |
| FourWorld Capital Management, LLC | 1.4% |
| Wexford Capital LP | 0.95% |
| UBS Group AG | 0.88% |
| Susquehanna International Group, LLP | 0.67% |
| Saba Capital Management, L.P. | 0.53% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 1.73% |
| Vanguard Group | 0.53% |
| Geode Capital | 0.52% |
Source: Nexqual, July 25, 2026 at 06:05 UTC.
From Airsculpt Technologies, Inc.'s Latest SEC 10-K Filing (filed 2026-03-31)
Key Strengths & Strategy (as disclosed to the SEC)
- AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada.
- The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure.
- It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool.
- In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient's own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RPID | Rapid Micro Biosystems, Inc. | USD 1.99 | ▼ 3.4% |
| SGHT | Sight Sciences, Inc. | USD 4.91 | ▼ 2.39% |
| TMCI | Treace Medical Concepts, Inc. | USD 4 | ▲ 0.76% |
| CTKB | Cytek Biosciences, Inc. | USD 4.46 | ▼ 1.76% |
| EXFY | Expensify, Inc. | USD 1.72 | ▼ 1.71% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 06:05 UTC. This page is informational and not investment advice.